ОбзорГрафикНовостиTraderScreen

Soc. Generale Bonus Zert QIA 26.0.../  DE000SJ2W000  /

Frankfurt Zert./SG
10.01.2025  21:40:39 Изменение-0.180 Бид21:59:47 Предложение21:59:47 Базовый актив Цена исполнения Дата истечения Тип опциона
43.930EUR -0.41% 43.830
Величина цены спроса: 1,000		 44.190
Величина цены предложения: 1,000		 QIAGEN NV - EUR 26.09.2025 Call
GlobeNewswire 28.08.2024 QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
TeleTrader 26.08.2024 Europe closes mixed amid Middle East crisis
GlobeNewswire 31.07.2024 QIAGEN delivers solid performance and exceeds outlook for Q2 2024
GlobeNewswire 31.07.2024 Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
GlobeNewswire 08.07.2024 QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire 02.07.2024 QIAGEN N.V. to release results for Q2 2024 and hold webcast
GlobeNewswire 27.06.2024 QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire 17.06.2024 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 13.06.2024 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 12.06.2024 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 11.06.2024 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 06.06.2024 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 05.06.2024 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 03.06.2024 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 30.05.2024 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 30.05.2024 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 29.05.2024 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 22.05.2024 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 14.05.2024 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 13.05.2024 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 07.05.2024 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 07.05.2024 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07.05.2024 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 02.05.2024 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 29.04.2024 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance